NO138026C - Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperazinerInfo
- Publication number
- NO138026C NO138026C NO2303/73A NO230373A NO138026C NO 138026 C NO138026 C NO 138026C NO 2303/73 A NO2303/73 A NO 2303/73A NO 230373 A NO230373 A NO 230373A NO 138026 C NO138026 C NO 138026C
- Authority
- NO
- Norway
- Prior art keywords
- analogical
- piperazines
- benzhydryl
- hydroxybenzyl
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2226767A DE2226767A1 (de) | 1972-06-02 | 1972-06-02 | N-benzhydryl-n'-p-hydroxybenzylpiperazin und verfahren zu seiner herstellung |
| DE19732312212 DE2312212A1 (de) | 1973-03-12 | 1973-03-12 | N-(p-chlorbenzhydryl)-n'-p-hydroxybenzyl-piperazin und verfahren zu seiner herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO138026B NO138026B (no) | 1978-03-06 |
| NO138026C true NO138026C (no) | 1978-06-14 |
Family
ID=25763357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2303/73A NO138026C (no) | 1972-06-02 | 1973-06-01 | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US3868377A (da) |
| JP (1) | JPS4948687A (da) |
| AR (5) | AR196936A1 (da) |
| AT (3) | AT331252B (da) |
| AU (1) | AU470393B2 (da) |
| BG (3) | BG20596A3 (da) |
| CA (1) | CA980347A (da) |
| CH (4) | CH579064A5 (da) |
| CS (4) | CS182234B2 (da) |
| DD (1) | DD106644A5 (da) |
| DK (1) | DK139751C (da) |
| EG (1) | EG11434A (da) |
| ES (3) | ES415466A1 (da) |
| FI (1) | FI55656C (da) |
| FR (1) | FR2186265B1 (da) |
| GB (1) | GB1386916A (da) |
| HU (1) | HU165312B (da) |
| IE (1) | IE37717B1 (da) |
| IL (1) | IL42384A (da) |
| NL (1) | NL7306771A (da) |
| NO (1) | NO138026C (da) |
| PH (1) | PH9485A (da) |
| PL (3) | PL94759B1 (da) |
| RO (3) | RO68378A (da) |
| SE (1) | SE396385B (da) |
| SU (4) | SU530644A3 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59101475A (ja) * | 1982-12-02 | 1984-06-12 | Nippon Chemiphar Co Ltd | 新規ピペラジン誘導体およびその製造法ならびにこれを含有する脳循環改善剤 |
| HU186656B (en) * | 1982-12-28 | 1985-09-30 | Richter Gedeon Vegyeszet | Process for producing new benzhydryl-piperazine derivatives, acid additionak salts and pharmaceutical compositions containing them |
| GB8320701D0 (en) * | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agent |
| JPS60222472A (ja) * | 1984-03-30 | 1985-11-07 | Kanebo Ltd | 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物 |
| ATE107296T1 (de) * | 1988-08-05 | 1994-07-15 | Nippon Chemiphar Co | Optisch aktive piperazin-derivate. |
| FR2661176B1 (fr) * | 1990-04-20 | 1992-06-12 | Adir | Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive. |
| BR9406080A (pt) * | 1993-12-08 | 1996-02-06 | Alcon Lab Inc | Compostos que tem tanto antividade de anaonista potente de calcio como de antioxidante e uso dos mesmos como agentes citoprotetores |
| WO2009147389A2 (en) * | 2008-06-02 | 2009-12-10 | Cipla Limited | Processes for the synthesis of levocetirizine and intermediates for use therein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2709169A (en) * | 1955-05-24 | X c chs | ||
| US3051710A (en) * | 1959-12-21 | 1962-08-28 | Lakeside Lab Inc | Glycolic acid amide derivatives of piperazine and use thereof |
-
1973
- 1973-05-15 NL NL7306771A patent/NL7306771A/xx not_active Application Discontinuation
- 1973-05-28 IE IE855/73A patent/IE37717B1/xx unknown
- 1973-05-29 RO RO7382539A patent/RO68378A/ro unknown
- 1973-05-29 CS CS7300003883A patent/CS182234B2/cs unknown
- 1973-05-29 CS CS3877A patent/CS178429B2/cs unknown
- 1973-05-29 RO RO7382540A patent/RO68379A/ro unknown
- 1973-05-29 BG BG026972A patent/BG20596A3/xx unknown
- 1973-05-29 BG BG023741A patent/BG20595A3/xx unknown
- 1973-05-29 CS CS3878A patent/CS178430B2/cs unknown
- 1973-05-29 CS CS7600004284A patent/CS182248B2/cs unknown
- 1973-05-29 IL IL42384A patent/IL42384A/en unknown
- 1973-05-29 US US364764A patent/US3868377A/en not_active Expired - Lifetime
- 1973-05-29 RO RO7374944A patent/RO62900A/ro unknown
- 1973-05-29 BG BG026973A patent/BG20371A3/xx unknown
- 1973-05-30 SE SE7307692A patent/SE396385B/xx unknown
- 1973-05-30 GB GB2571073A patent/GB1386916A/en not_active Expired
- 1973-05-31 AU AU56343/73A patent/AU470393B2/en not_active Expired
- 1973-05-31 SU SU1926942A patent/SU530644A3/ru active
- 1973-05-31 PL PL1973186639A patent/PL94759B1/pl unknown
- 1973-05-31 PL PL1973162986A patent/PL91050B1/pl unknown
- 1973-05-31 DD DD171224A patent/DD106644A5/xx unknown
- 1973-05-31 JP JP48060375A patent/JPS4948687A/ja active Pending
- 1973-05-31 AR AR248325A patent/AR196936A1/es active
- 1973-05-31 CA CA172,824A patent/CA980347A/en not_active Expired
- 1973-05-31 PL PL1973186638A patent/PL97129B1/pl unknown
- 1973-05-31 HU HUCA347A patent/HU165312B/hu unknown
- 1973-05-31 EG EG206/73A patent/EG11434A/xx active
- 1973-05-31 PH PH14678*UA patent/PH9485A/en unknown
- 1973-05-31 SU SU1926943A patent/SU508196A3/ru active
- 1973-05-31 AR AR248327A patent/AR201001A1/es active
- 1973-05-31 AR AR248326A patent/AR194688A1/es active
- 1973-05-31 SU SU1926939A patent/SU507238A3/ru active
- 1973-06-01 AT AT483273A patent/AT331252B/de not_active IP Right Cessation
- 1973-06-01 ES ES415466A patent/ES415466A1/es not_active Expired
- 1973-06-01 FI FI1797/73A patent/FI55656C/fi active
- 1973-06-01 FR FR7319998A patent/FR2186265B1/fr not_active Expired
- 1973-06-01 AT AT483173A patent/AT331802B/de not_active IP Right Cessation
- 1973-06-01 NO NO2303/73A patent/NO138026C/no unknown
- 1973-06-01 ES ES415464A patent/ES415464A1/es not_active Expired
- 1973-06-01 AT AT483073A patent/AT331801B/de not_active IP Right Cessation
- 1973-06-01 DK DK304673A patent/DK139751C/da active
- 1973-06-01 ES ES73415465A patent/ES415465A1/es not_active Expired
- 1973-06-04 CH CH802973A patent/CH579064A5/xx not_active IP Right Cessation
- 1973-06-04 CH CH803073A patent/CH593959A5/xx not_active IP Right Cessation
- 1973-06-04 CH CH802873A patent/CH574949A5/xx not_active IP Right Cessation
- 1973-06-04 CH CH1193576A patent/CH594651A5/xx not_active IP Right Cessation
-
1974
- 1974-01-01 AR AR252417A patent/AR204987A1/es active
- 1974-02-18 AR AR252416A patent/AR200764A1/es active
- 1974-12-13 SU SU7402082532A patent/SU577995A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
| NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
| NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO138335C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer | |
| NO137440C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner | |
| NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
| NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
| NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
| NO142033C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler | |
| NO137782C (no) | Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer | |
| NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
| NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
| NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
| NO140596C (no) | Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner | |
| NO138026C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
| NO139088C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner | |
| NO138063C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater | |
| NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
| NO137151C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider | |
| NO138025C (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
| NO138251C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer | |
| NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
| NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner | |
| NO137727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener | |
| NO137695C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser |